KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Free Cash Flow (2016 - 2026)

Amgen has reported Free Cash Flow over the past 18 years, most recently at $1.5 billion for Q1 2026.

  • For Q1 2026, Free Cash Flow rose 50.71% year-over-year to $1.5 billion; the TTM value through Mar 2026 reached $8.6 billion, down 21.24%, while the annual FY2025 figure was $8.1 billion, 22.07% down from the prior year.
  • Free Cash Flow for Q1 2026 was $1.5 billion at Amgen, up from $961.0 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $4.4 billion in Q4 2024 and troughed at $289.0 million in Q4 2023.
  • A 5-year average of $2.1 billion and a median of $2.0 billion in 2022 define the central range for Free Cash Flow.
  • Biggest five-year swings in Free Cash Flow: plummeted 87.48% in 2023 and later skyrocketed 1422.49% in 2024.
  • Year by year, Free Cash Flow stood at $2.3 billion in 2022, then tumbled by 87.48% to $289.0 million in 2023, then skyrocketed by 1422.49% to $4.4 billion in 2024, then tumbled by 78.16% to $961.0 million in 2025, then surged by 53.69% to $1.5 billion in 2026.
  • Business Quant data shows Free Cash Flow for AMGN at $1.5 billion in Q1 2026, $961.0 million in Q4 2025, and $4.2 billion in Q3 2025.